- Home
- AWRE vs CASI Comparison
AWRE vs CASI Comparison
Compare AWRE & CASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AWRE
- CASI
- Stock Information
- Founded
- AWRE 1986
- CASI 1991
- Country
- AWRE United States
- CASI China
- Employees
- AWRE N/A
- CASI N/A
- Industry
- AWRE Computer Software: Prepackaged Software
- CASI Biotechnology: Pharmaceutical Preparations
- Sector
- AWRE Technology
- CASI Health Care
- Exchange
- AWRE Nasdaq
- CASI Nasdaq
- Market Cap
- AWRE 34.6M
- CASI 29.7M
- IPO Year
- AWRE 1996
- CASI 1996
- Fundamental
- Price
- AWRE $1.68
- CASI $1.89
- Analyst Decision
- AWRE
- CASI Strong Buy
- Analyst Count
- AWRE 0
- CASI 1
- Target Price
- AWRE N/A
- CASI $4.00
- AVG Volume (30 Days)
- AWRE 29.9K
- CASI 7.1K
- Earning Date
- AWRE 04-30-2025
- CASI 05-16-2025
- Dividend Yield
- AWRE N/A
- CASI N/A
- EPS Growth
- AWRE N/A
- CASI N/A
- EPS
- AWRE N/A
- CASI N/A
- Revenue
- AWRE $16,576,000.00
- CASI $31,368,000.00
- Revenue This Year
- AWRE N/A
- CASI N/A
- Revenue Next Year
- AWRE N/A
- CASI N/A
- P/E Ratio
- AWRE N/A
- CASI N/A
- Revenue Growth
- AWRE N/A
- CASI 8.39
- 52 Week Low
- AWRE $1.35
- CASI $1.64
- 52 Week High
- AWRE $2.97
- CASI $7.67
- Technical
- Relative Strength Index (RSI)
- AWRE 55.69
- CASI 47.25
- Support Level
- AWRE $1.60
- CASI $1.77
- Resistance Level
- AWRE $1.72
- CASI $1.98
- Average True Range (ATR)
- AWRE 0.07
- CASI 0.10
- MACD
- AWRE -0.00
- CASI 0.01
- Stochastic Oscillator
- AWRE 71.43
- CASI 54.55
About AWRE Aware Inc.
Aware Inc is a provider of software and services to the biometrics industry. The company's software products are used in government and commercial biometrics systems to identify or authenticate people. The government applications of biometrics systems include border control, visa applicant screening, law enforcement, national defense, intelligence, secure credentialing, access control, and background checks. Its commercial applications include user authentication for login to mobile devices, computers, networks, and software programs, user authentication for financial transactions and purchases. Its geographical segments include the United States, the United Kingdom, and the Rest of the world, out of which it derives maximum revenue from United States.
About CASI CASI Pharmaceuticals Inc.
CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.